Josh Leisring
@joshleisring.bsky.social
220 followers 120 following 86 posts
Nephrologist / Hypertension Specialist in Columbus, Ohio #Nephsky He / him
Posts Media Videos Starter Packs
joshleisring.bsky.social
Donate and represent!
#NephJC
Reposted by Josh Leisring
kentkidneydoc.bsky.social
Our @ukkidney.org guidelines here in BMC Nephrology. 💯% agree that in-unit BP should ONLY be used for determining safety of individual HD sessions and NOT long-term CV risk modification. But changing practice will be a long haul.

link.springer.com/epdf/10.1186...
Management of blood pressure in adults, children and young people on dialysis: UK kidney association clinical practice guideline
link.springer.com
Reposted by Josh Leisring
giaconajohn.bsky.social
Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>
Reposted by Josh Leisring
nephroseeker.medsky.social
#NephJC is a labor of a passionate volunteer team that believes education should be accessible, no matter where you are from in the world.

Even if editorial team donates unlimited hours of sleep, there are still costs to cover 💸 (👇 blog)

😊 Be kind, help us to #NephItForward

#Medsky #Nephsky
nephjc.bsky.social
It's that time of year again 🍂🍂🍂
The #NephJC Fall pledge drive.
Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky
www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive
NephJC 2025 Fall Pledge Drive — NephJC
Help keep NephJC a vital, original, and unbiased source of medical education.
www.nephjc.com
Reposted by Josh Leisring
bhallaresearch.bsky.social
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertension/e…

-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
https://med.stanford.edu/hypertension/e…
Reposted by Josh Leisring
nephjc.bsky.social
It's that time of year again 🍂🍂🍂
The #NephJC Fall pledge drive.
Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky
www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive
NephJC 2025 Fall Pledge Drive — NephJC
Help keep NephJC a vital, original, and unbiased source of medical education.
www.nephjc.com
Reposted by Josh Leisring
goupilremi.bsky.social
🚨 Survey Alert!
Standardized office BP measurements are recommended everywhere, but still underused.
We want to hear from you: what are the barriers to using them as a routine in clinical practice?

Click here to read the consent form and take the survey:
redcap.link/barriers.to....
Reposted by Josh Leisring
soumya-goblue.medsky.social
My guess is at least 500 #doctors at my #hospital are on H1B visas including at least a few dozen #hospitalists, and if we lose even a handful to other countries our house of cards #healthcare system will fall apart, let alone all 500+
joshleisring.bsky.social
At our center we do the initial screen without altering the existing meds. Don’t wanna miss the opportunity. Patients with the most overt PA have suppressed renin even on RAASi+thiazide. If results aren’t conclusive and suspicion still there can then washout or try empiric MRA. #NephJC
joshleisring.bsky.social
Reposting this again - very relevant for #NephJC discussion on the new AHA/ACC guidelines.
anandvaidya17.bsky.social
To accompany the new ACC/AHA BP guidelines, a practical guide on how to test for Primary Aldosteronism: now recommended for most people with hypertension.

www.jacc.org/doi/10.1016/...
joshleisring.bsky.social
Agree, screening seems like the most effective avenue to improve treatment rates on a broad scale.

Also, screening and making the diagnosis of PA in an individual patient allows tailored treatment including follow-up on plasma renin to help guide dose titration to get full benefit of MRA

#NephJC
Reposted by Josh Leisring
anandvaidya17.bsky.social
To accompany the new ACC/AHA BP guidelines, a practical guide on how to test for Primary Aldosteronism: now recommended for most people with hypertension.

www.jacc.org/doi/10.1016/...
Reposted by Josh Leisring
anandvaidya17.bsky.social
Confirmatory testing (aldosterone suppression testing) for primary aldosteronism: not reliable, or reproducible, for diagnosis or predicting lateralization. Sensitivity at the expense of specificity, and vice-versa. Time to simplify the process

academic.oup.com/ejendo/artic...
Discordance and shortcomings of aldosterone suppression tests in primary aldosteronism
AbstractBackground. The saline suppression test (SST) and the captopril challenge test (CCT) have traditionally been used to confirm or exclude primary ald
academic.oup.com
Reposted by Josh Leisring
giaconajohn.bsky.social
❓What’s new in BP care?
🎥 Watch the #TargetBP webinar on the 2025 @AHAScience / @ACCinTouch Hypertension Guidelines w/ @drwanpen.bsky.social , @jordybc.bsky.social , Keith Ferdinand, & Dan Jones 👉 targetbp.org
joshleisring.bsky.social
This is excellent! Multiple nice learning points all in one well-written case report.
Reposted by Josh Leisring
hswapnil.medsky.social
The CPC from last @ahascience.bsky.social #HypertensionSessions now published in @ahajournals.bsky.social

www.ahajournals.org/doi/10.1161/...

thanks to @drjmluther.bsky.social and all the education editors for the invite

We hope it makes for an educational read!
joshleisring.bsky.social
Implementing will be a challenge but that shouldn't discourage broader screening.

From the recent Endo Society guideline - the majority of these newly detected cases can be managed with MRA.
joshleisring.bsky.social
Commentary on expanded screening for primary aldosteronism in the new HTN guideline.

www.ahajournals.org/doi/10.1161/... 🔓
Reposted by Josh Leisring